Computed Tomography of Liver With and Without Enhancement Show: 
 
CT of the liver with pre-contrast & triphasic contrast enhancement studies show:   
Techniques:  
From lower chest to liver inferior edge in 5-mm contiguous section  
Contrast agent  injected at 2ml/sec, 30 sec after initiation of injection, starting arterial phase scan; portal phase scan performed in 20 sec after the end of the arterial phase scan; and venous phase scan began in 20 sec after the end of portal phase scan 
 
Findings: 
 
Calcification of coronary artery at risk of coronary artery disease.    
No definite pulmonary nodule in visual field. 
Duodenal diverticulum (5.2cm) 
No definite space occupying lesion in the spleen and pancreas. 
S7-8 liver heterogeneous enhancing mass (10x12cm) with central necrosis, possible right posterior superior portal vein and RHV invasion 
No definite biliary dilatation  . 
Gallbladder stones. 
Patency of portal vein    
No definite hydronephrosis. 
Left renal cyst with wall calcification 
Air density in urinary bladder and left renal upper calyx  
Lobulated contour of bil. kidney  
No definite enlargement of retroperitoneal LNs  . 
A-colon diverticula  
No abnormal fluid collection or free air in the abdomen  . 
No definite bone destruction. 
T11 vertebral compression fracture  
Enlarged uterus , maybe due to myoma  
Kindly note that subtle mucosal lesion could not be well evaluated on routine CT. 
 
IMP: 
 
1.S7-8 liver heterogeneous enhancing mass (10x12cm) with possible right posterior superior portal vein and RHV invasion. Suspect HCC. 
2.Bil.chronic kidney disease 
3.Gallbladder stones. 
 
¡´Imaging Report Form for Hepatocellua Carcinoma (AJCC 8th Edition) 
1.Tumor Number/Location:  
Number: ¡´1 ¡³2 ¡³3 Multiple: 
Location: ¡¼  
2.Tumor Size:  
    ¡´Measurable:  12cm (the largest tumor) 
    ¡³Non-measurable 
3.Tumor Characteristics and Associated Liver Features 
    ¡´Vascular invasion  
    ¡³Extrahepatic spread  
    ¡³Ascites  
    ¡³Portal vein thrombosis, location  
    ¡³Portosystemic collateral vessel 
    ¡³Typical enhancement pattern (hypervascular enhancement and early wash-out) 
3.Pathology: ¡´Not available ¡³Available (Pathology type:¡¼) 
 
-------------------Primary Tumor(T)-------------------------- 
 Tx  ¡³ Primary tumor cannot be assessed  
 T0  ¡³ No primary tumor  
Stage I 
T1   ¡³ Solitary tumor ¡Ø2 cm, or ¡r 2cm without vascular invasion 
T1a  Solitary tumor ¡Ø2 cm 
T1b  Solitary tumor ¡r 2cm without vascular invasion 
Stage II 
T2   ¡³ Solitary tumor ¡r2cm with vascular invasion, or multiple tumors,none ¡r5cm  
Stage III 
T3   ¡³Multiple tumors more than 5 cm  
T4   ¡´Single tumor or multiple tumors of any size involving a major 
branch of the portal vein or hepatic vein, or tumor(s) with direct 
invasion of adjacent organs other than the gallbladder or with 
perforation of visceral peritoneum  
-------------------Regional Lymph Nodes(N)----------------- 
Nx   ¡³Regional lymph nodes cannot be assessed  
N0   ¡´No regional lymph nodes 
Stage IVA 
N1   ¡³Regional lymph node metastasis  
     ¡³Periceliac, ¡³Hilar( common bile duct, hepatic artery, portal vein and cystic duct) ¡³Peripancreatic ¡³Paraaortic ¡³Portocaval ¡³Retrocaval 
¡³Others_______  
-------------------Distant Metastasis(M)---------------------- 
Stage IVB 
M1  ¡³Distant metastasis 
¡³ Invasion of gallbladder 
¡³ Cardiophrenic, Mesenteric, Retrocrural LN 
Imaging stage   T4 N0 Mx( in this study) 
 